Advertisement

Genetics in Movement Disorder Phenomenology

  • Steven J. FruchtEmail author
  • Pichet Termsarasab
Chapter
  • 43 Downloads

Abstract

The last quarter century has witnessed a remarkable transformation in our understanding of the role of genetics in movement disorders. Modern genetic techniques allow specific diagnoses to be secured in many hereditary and “sporadic” movement disorders. This chapter illustrates the many advances in this field.

Keywords

Whole exome sequencing Whole genome sequencing Variant of unknown significance 

References

  1. 1.
    Tan EK, Teo YY, Prakash KM, Li R, Lim HQ, Angeles D, et al. LINGO1 variant increases risk of familial essential tremor. Neurology. 2009;73(14):1161–2.  https://doi.org/10.1212/WNL.0b013e3181bacfc9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Clark LN, Park N, Kisselev S, Rios E, Lee JH, Louis ED. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet. 2010;18(7):838–43.  https://doi.org/10.1038/ejhg.2010.27.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Stefansson H, Steinberg S, Petursson H, Gustafsson O, Gudjonsdottir IH, Jonsdottir GA, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet. 2009;41(3):277–9.  https://doi.org/10.1038/ng.299.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Deng H, Le WD, Xie WJ, Jankovic J. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand. 2006;114(6):400–2.  https://doi.org/10.1111/j.1600-0404.2006.00706.x.CrossRefPubMedGoogle Scholar
  5. 5.
    Grados MA, Walkup JT. A new gene for Tourette’s syndrome: a window into causal mechanisms? Trends Genet. 2006;22(6):291–3.  https://doi.org/10.1016/j.tig.2006.04.003.CrossRefPubMedGoogle Scholar
  6. 6.
    Abelson JF, Kwan KY, O’Roak BJ, Baek DY, Stillman AA, Morgan TM, et al. Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science. 2005;310(5746):317–20.  https://doi.org/10.1126/science.1116502.CrossRefPubMedGoogle Scholar
  7. 7.
    Wang S, Mandell JD, Kumar Y, Sun N, Morris MT, Arbelaez J, et al. De Novo sequence and copy number variants are strongly associated with Tourette disorder and implicate cell polarity in pathogenesis. Cell Rep. 2018;24(13):3441–54 e12.  https://doi.org/10.1016/j.celrep.2018.08.082.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    European Society of Human G. Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2009;17(6):720–1.  https://doi.org/10.1038/ejhg.2009.26.CrossRefGoogle Scholar
  9. 9.
    Meienberg J, Zerjavic K, Keller I, Okoniewski M, Patrignani A, Ludin K, et al. New insights into the performance of human whole-exome capture platforms. Nucleic Acids Res. 2015;43(11):e76.  https://doi.org/10.1093/nar/gkv216.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Meynert AM, Bicknell LS, Hurles ME, Jackson AP, Taylor MS. Quantifying single nucleotide variant detection sensitivity in exome sequencing. BMC Bioinformatics. 2013;14:195.  https://doi.org/10.1186/1471-2105-14-195.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Didonna A, Opal P. Advances in sequencing technologies for understanding hereditary ataxias: a review. JAMA Neurol. 2016;73(12):1485–90.  https://doi.org/10.1001/jamaneurol.2016.3097.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Thompson AJ, Subramony SH, Okun MS. I spy apraxic eyes in spinocerebellar ataxia type 2: a false-negative ataxia panel. Mov Disord. 2014;29(3):426–7.CrossRefGoogle Scholar
  13. 13.
    Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747–53.  https://doi.org/10.1038/nature08494.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet. 2017;49(10):1511–6.  https://doi.org/10.1038/ng.3955.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lohmann K, Schmidt A, Schillert A, Winkler S, Albanese A, Baas F, et al. Genome-wide association study in musician’s dystonia: a risk variant at the arylsulfatase G locus? Mov Disord. 2014;29(7):921–7.  https://doi.org/10.1002/mds.25791.CrossRefPubMedGoogle Scholar
  16. 16.
    Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.  https://doi.org/10.1038/gim.2015.30.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Risch NJ, Bressman SB, deLeon D, Brin MF, Burke RE, Greene PE, et al. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am J Hum Genet. 1990;46(3):533–8.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Saunders-Pullman R, Raymond D, Senthil G, Kramer P, Ohmann E, Deligtisch A, et al. Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-Mennonites. Am J Med Genet A. 2007;143A(18):2098–105.  https://doi.org/10.1002/ajmg.a.31887.CrossRefPubMedGoogle Scholar
  19. 19.
    Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol. 2008;7(7):583–90.  https://doi.org/10.1016/S1474-4422(08)70117-0.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Marder K, Wang Y, Alcalay RN, Mejia-Santana H, Tang MX, Lee A, et al. Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 consortium. Neurology. 2015;85(1):89–95.  https://doi.org/10.1212/WNL.0000000000001708.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Movement DisordersNew York University Grossman School of Medicine, The Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders, NYU Langone HealthNew YorkUSA
  2. 2.Division of Neurology, Faculty of MedicineRamathibodi Hospital, Mahidol UniversityBangkokThailand

Personalised recommendations